BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Iacobazzi RM, Porcelli L, Lopedota AA, Laquintana V, Lopalco A, Cutrignelli A, Altamura E, Di Fonte R, Azzariti A, Franco M, Denora N. Targeting human liver cancer cells with lactobionic acid-G(4)-PAMAM-FITC sorafenib loaded dendrimers. Int J Pharm 2017;528:485-97. [PMID: 28624661 DOI: 10.1016/j.ijpharm.2017.06.049] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Cevik E. High Sensitive Detection of Prostate Specific Antigen by Using Ferrocene Cored Asymmetric PAMAM Dendrimer Interface Screen Printed Electrodes. Electroanalysis 2019;31:31-9. [DOI: 10.1002/elan.201800440] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Argenziano M, Arpicco S, Brusa P, Cavalli R, Chirio D, Dosio F, Gallarate M, Peira E, Stella B, Ugazio E. Developing Actively Targeted Nanoparticles to Fight Cancer: Focus on Italian Research. Pharmaceutics 2021;13:1538. [PMID: 34683830 DOI: 10.3390/pharmaceutics13101538] [Reference Citation Analysis]
3 Ghalehkhondabi V, Soleymani M, Fazlali A. Folate-targeted nanomicelles containing silibinin as an active drug delivery system for liver cancer therapy. Journal of Drug Delivery Science and Technology 2021;61:102157. [DOI: 10.1016/j.jddst.2020.102157] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
4 Iacobazzi RM, Vischio F, Arduino I, Canepa F, Laquintana V, Notarnicola M, Scavo MP, Bianco G, Fanizza E, Lopedota AA, Cutrignelli A, Lopalco A, Azzariti A, Curri ML, Franco M, Giannelli G, Lee BC, Depalo N, Denora N. Magnetic implants in vivo guiding sorafenib liver delivery by superparamagnetic solid lipid nanoparticles. J Colloid Interface Sci 2021;608:239-54. [PMID: 34626971 DOI: 10.1016/j.jcis.2021.09.174] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Porcelli L, Mazzotta A, Garofoli M, Di Fonte R, Guida G, Guida M, Tommasi S, Azzariti A. Active notch protects MAPK activated melanoma cell lines from MEK inhibitor cobimetinib. Biomed Pharmacother 2021;133:111006. [PMID: 33202284 DOI: 10.1016/j.biopha.2020.111006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Arduino I, Iacobazzi RM, Riganti C, Lopedota AA, Perrone MG, Lopalco A, Cutrignelli A, Cantore M, Laquintana V, Franco M, Colabufo NA, Luurtsema G, Contino M, Denora N. Induced expression of P-gp and BCRP transporters on brain endothelial cells using transferrin functionalized nanostructured lipid carriers: A first step of a potential strategy for the treatment of Alzheimer's disease. Int J Pharm 2020;591:120011. [PMID: 33115695 DOI: 10.1016/j.ijpharm.2020.120011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
7 Siciliano G, Corricelli M, Iacobazzi RM, Canepa F, Comegna D, Fanizza E, Del Gatto A, Saviano M, Laquintana V, Comparelli R, Mascolo G, Murgolo S, Striccoli M, Agostiano A, Denora N, Zaccaro L, Curri ML, Depalo N. Gold-Speckled SPION@SiO2 Nanoparticles Decorated with Thiocarbohydrates for ASGPR1 Targeting: Towards HCC Dual Mode Imaging Potential Applications. Chemistry 2020;26:11048-59. [PMID: 32628283 DOI: 10.1002/chem.202002142] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Gao X, He Z, Ni W, Jian X, Hu C, Zhao Y, Yan Y, Wei X. Layer‐by‐Layer Assembly of Functional Nanoparticles for Hepatocellular Carcinoma Therapy. Adv Funct Mater 2019;29:1904246. [DOI: 10.1002/adfm.201904246] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
9 Visentin S, Sedić M, Pavelić SK, Pavelić K. Targeting Tumour Metastasis: The Emerging Role of Nanotechnology. CMC 2020;27:1367-81. [DOI: 10.2174/0929867326666181220095343] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Saadat M, Mostafaei F, Mahdinloo S, Abdi M, Zahednezhad F, Zakeri-milani P, Valizadeh H. Drug delivery of pH-Sensitive nanoparticles into the liver cancer cells. Journal of Drug Delivery Science and Technology 2021;63:102557. [DOI: 10.1016/j.jddst.2021.102557] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
11 Wang S, Xing J, Xiong B, Han H, Hu M, Li Q. Fluoropolymer-Mediated Intracellular Delivery of miR-23b for the Osteocyte Differentiation in Osteoblasts. Macromol Biosci 2021;21:e2100024. [PMID: 33713529 DOI: 10.1002/mabi.202100024] [Reference Citation Analysis]
12 Mahmoudi A, Jaafari MR, Ramezanian N, Gholami L, Malaekeh-nikouei B. BR2 and CyLoP1 enhance in-vivo SN38 delivery using pegylated PAMAM dendrimers. International Journal of Pharmaceutics 2019;564:77-89. [DOI: 10.1016/j.ijpharm.2019.04.037] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
13 Rompicharla SVK, Kumari P, Bhatt H, Ghosh B, Biswas S. Biotin functionalized PEGylated poly(amidoamine) dendrimer conjugate for active targeting of paclitaxel in cancer. Int J Pharm 2019;557:329-41. [PMID: 30599231 DOI: 10.1016/j.ijpharm.2018.12.069] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
14 Phan C, Zheng Z, Wang J, Wang Q, Hu X, Tang G, Bai H. Enhanced antitumour effect for hepatocellular carcinoma in the advanced stage using a cyclodextrin-sorafenib-chaperoned inclusion complex. Biomater Sci 2019;7:4758-68. [PMID: 31509117 DOI: 10.1039/c9bm01190k] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Lopalco A, Cutrignelli A, Denora N, Perrone M, Iacobazzi RM, Fanizza E, Lopedota A, Depalo N, de Candia M, Franco M, Laquintana V. Delivery of Proapoptotic Agents in Glioma Cell Lines by TSPO Ligand-Dextran Nanogels. Int J Mol Sci 2018;19:E1155. [PMID: 29641449 DOI: 10.3390/ijms19041155] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
16 Sommonte F, Arduino I, Racaniello GF, Lopalco A, Lopedota AA, Denora N. The Complexity of the Blood-Brain Barrier and the Concept of Age-Related Brain Targeting: Challenges and Potential of Novel Solid Lipid-Based Formulations. J Pharm Sci 2021:S0022-3549(21)00462-7. [PMID: 34469749 DOI: 10.1016/j.xphs.2021.08.029] [Reference Citation Analysis]
17 Pisani L, Iacobazzi RM, Catto M, Rullo M, Farina R, Denora N, Cellamare S, Altomare CD. Investigating alkyl nitrates as nitric oxide releasing precursors of multitarget acetylcholinesterase-monoamine oxidase B inhibitors. European Journal of Medicinal Chemistry 2019;161:292-309. [DOI: 10.1016/j.ejmech.2018.10.016] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
18 Elfiky AM, Mohamed RH, Abd El-Hakam FE, Yassin MA, ElHefnawi M. Targeted delivery of miR-218 via decorated hyperbranched polyamidoamine for liver cancer regression. Int J Pharm 2021;610:121256. [PMID: 34732362 DOI: 10.1016/j.ijpharm.2021.121256] [Reference Citation Analysis]
19 Kheraldine H, Gupta I, Alhussain H, Jabeen A, Cyprian FS, Akhtar S, Al Moustafa AE, Rachid O. Substantial cell apoptosis provoked by naked PAMAM dendrimers in HER2-positive human breast cancer via JNK and ERK1/ERK2 signalling pathways. Comput Struct Biotechnol J 2021;19:2881-90. [PMID: 34093999 DOI: 10.1016/j.csbj.2021.05.011] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
20 Russo E, Spallarossa A, Tasso B, Villa C, Brullo C. Nanotechnology of Tyrosine Kinase Inhibitors in Cancer Therapy: A Perspective. Int J Mol Sci 2021;22:6538. [PMID: 34207175 DOI: 10.3390/ijms22126538] [Reference Citation Analysis]
21 Fanizza E, Depalo N, Fedorenko S, Iacobazzi RM, Mukhametshina A, Zairov R, Salatino A, Vischio F, Panniello A, Laquintana V, Curri ML, Mustafina A, Denora N, Striccoli M. Green Fluorescent Terbium (III) Complex Doped Silica Nanoparticles. Int J Mol Sci 2019;20:E3139. [PMID: 31252567 DOI: 10.3390/ijms20133139] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
22 Mazumder A, Dwivedi A, Assawapanumat W, Saeeng R, Sungkarat W, Nasongkla N. In vitro galactose-targeted study of RSPP050-loaded micelles against liver hepatocellular carcinoma. Pharm Dev Technol 2022;:1-13. [PMID: 35388736 DOI: 10.1080/10837450.2022.2063891] [Reference Citation Analysis]
23 Iacobazzi RM, Cutrignelli A, Stefanachi A, Porcelli L, Lopedota AA, Di Fonte R, Lopalco A, Serratì S, Laquintana V, Silvestris N, Franco M, Cellamare S, Leonetti F, Azzariti A, Denora N. Hydroxy-Propil-β-Cyclodextrin Inclusion Complexes of two Biphenylnicotinamide Derivatives: Formulation and Anti-Proliferative Activity Evaluation in Pancreatic Cancer Cell Models. Int J Mol Sci 2020;21:E6545. [PMID: 32906812 DOI: 10.3390/ijms21186545] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Ailuno G, Iacobazzi RM, Lopalco A, Baldassari S, Arduino I, Azzariti A, Pastorino S, Caviglioli G, Denora N. The Pharmaceutical Technology Approach on Imaging Innovations from Italian Research. Pharmaceutics 2021;13:1214. [PMID: 34452175 DOI: 10.3390/pharmaceutics13081214] [Reference Citation Analysis]
25 Titov AA, Kobzev MS, Catto M, Candia M, Gambacorta N, Denora N, Pisani L, Nicolotti O, Borisova TN, Varlamov AV, Voskressensky LG, Altomare CD. Away from Flatness: Unprecedented Nitrogen-Bridged Cyclopenta[a]indene Derivatives as Novel Anti-Alzheimer Multitarget Agents. ACS Chem Neurosci 2021;12:340-53. [PMID: 33395258 DOI: 10.1021/acschemneuro.0c00706] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
26 Mukwaya V, Wang C, Dou H. Saccharide-based nanocarriers for targeted therapeutic and diagnostic applications: Saccharide-based nanocarriers for therapeutics and diagnostics. Polym Int 2019;68:306-19. [DOI: 10.1002/pi.5702] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
27 Ghaffari M, Dehghan G, Abedi-Gaballu F, Kashanian S, Baradaran B, Ezzati Nazhad Dolatabadi J, Losic D. Surface functionalized dendrimers as controlled-release delivery nanosystems for tumor targeting. Eur J Pharm Sci 2018;122:311-30. [PMID: 30003954 DOI: 10.1016/j.ejps.2018.07.020] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 10.5] [Reference Citation Analysis]
28 Liang W, Dong Y, Shao R, Zhang S, Wu X, Huang X, Sun B, Zeng B, Zhao J. Application of Nanoparticles in Drug Delivery for the Treatment of Osteosarcoma: Focusing on the Liposomes. J Drug Target 2021;:1-39. [PMID: 34962448 DOI: 10.1080/1061186X.2021.2023160] [Reference Citation Analysis]
29 Gong X, Zheng Y, He G, Chen K, Zeng X, Chen Z. Multifunctional nanoplatform based on star-shaped copolymer for liver cancer targeting therapy. Drug Deliv 2019;26:595-603. [PMID: 31195837 DOI: 10.1080/10717544.2019.1625467] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
30 Lopalco A, Denora N. Nanoformulations for Drug Delivery: Safety, Toxicity, and Efficacy. Methods Mol Biol 2018;1800:347-65. [PMID: 29934902 DOI: 10.1007/978-1-4939-7899-1_17] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
31 Navya PN, Kaphle A, Srinivas SP, Bhargava SK, Rotello VM, Daima HK. Current trends and challenges in cancer management and therapy using designer nanomaterials. Nano Converg 2019;6:23. [PMID: 31304563 DOI: 10.1186/s40580-019-0193-2] [Cited by in Crossref: 149] [Cited by in F6Publishing: 100] [Article Influence: 49.7] [Reference Citation Analysis]
32 Porcelli L, Iacobazzi RM, Di Fonte R, Serratì S, Intini A, Solimando AG, Brunetti O, Calabrese A, Leonetti F, Azzariti A, Silvestris N. CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer. Cancers (Basel) 2019;11:E330. [PMID: 30866547 DOI: 10.3390/cancers11030330] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 15.7] [Reference Citation Analysis]
33 Arduino I, Liu Z, Iacobazzi RM, Lopedota AA, Lopalco A, Cutrignelli A, Laquintana V, Porcelli L, Azzariti A, Franco M, Santos HA, Denora N. Microfluidic preparation and in vitro evaluation of iRGD-functionalized solid lipid nanoparticles for targeted delivery of paclitaxel to tumor cells. Int J Pharm 2021;610:121246. [PMID: 34737115 DOI: 10.1016/j.ijpharm.2021.121246] [Reference Citation Analysis]
34 Rahman HS, Othman HH, Hammadi NI, Yeap SK, Amin KM, Abdul Samad N, Alitheen NB. Novel Drug Delivery Systems for Loading of Natural Plant Extracts and Their Biomedical Applications. Int J Nanomedicine 2020;15:2439-83. [PMID: 32346289 DOI: 10.2147/IJN.S227805] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
35 Denora N, Lee C, Iacobazzi RM, Choi JY, Song IH, Yoo JS, Piao Y, Lopalco A, Leonetti F, Lee BC, Kim SE. TSPO-targeted NIR-fluorescent ultra-small iron oxide nanoparticles for glioblastoma imaging. Eur J Pharm Sci 2019;139:105047. [PMID: 31422171 DOI: 10.1016/j.ejps.2019.105047] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
36 Alonso S. Exploiting the bioengineering versatility of lactobionic acid in targeted nanosystems and biomaterials. Journal of Controlled Release 2018;287:216-34. [DOI: 10.1016/j.jconrel.2018.08.030] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
37 Shinde A, Panchal K, Katke S, Paliwal R, Chaurasiya A. Tyrosine kinase inhibitors as next generation oncological therapeutics: Current strategies, limitations and future perspectives. Therapie 2021:S0040-5957(21)00215-8. [PMID: 34823895 DOI: 10.1016/j.therap.2021.10.010] [Reference Citation Analysis]
38 Gao W, Jia X, Wu J, Song Y, Yin J, Zhang M, Qiu N, Li X, Wu P, Qi X, Liu Z. Preparation and evaluation of folate-decorated human serum albumin nanoparticles for the targeted delivery of sorafenib to enhance antihepatocarcinoma efficacy. Journal of Drug Delivery Science and Technology 2019;54:101349. [DOI: 10.1016/j.jddst.2019.101349] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Porcelli L, Garofoli M, Di Fonte R, Fucci L, Volpicella M, Strippoli S, Guida M, Azzariti A. The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study. Sci Rep 2020;10:10465. [PMID: 32591592 DOI: 10.1038/s41598-020-67342-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]